Fulgent Genetics (FLGT) Total Non-Current Liabilities (2016 - 2025)
Fulgent Genetics' Total Non-Current Liabilities history spans 9 years, with the latest figure at $86.2 million for Q3 2025.
- For Q3 2025, Total Non-Current Liabilities changed N/A year-over-year to $86.2 million; the TTM value through Sep 2025 reached $86.2 million, changed N/A, while the annual FY2024 figure was $83.8 million, 3.59% down from the prior year.
- Total Non-Current Liabilities for Q3 2025 was $86.2 million at Fulgent Genetics, up from $83.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $197.0 million in Q1 2021 and bottomed at $80.8 million in Q3 2023.
- The 5-year median for Total Non-Current Liabilities is $97.9 million (2022), against an average of $112.3 million.
- The largest annual shift saw Total Non-Current Liabilities soared 166.28% in 2021 before it tumbled 37.01% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $106.0 million in 2021, then dropped by 7.63% to $97.9 million in 2022, then dropped by 11.22% to $87.0 million in 2023, then fell by 3.59% to $83.8 million in 2024, then increased by 2.88% to $86.2 million in 2025.
- Per Business Quant, the three most recent readings for FLGT's Total Non-Current Liabilities are $86.2 million (Q3 2025), $83.8 million (Q4 2024), and $89.0 million (Q2 2024).